The Oncology Institute Inc./$TOI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
Ticker
$TOI
Sector
Primary listing
Employees
825
Headquarters
Website
TOI Metrics
BasicAdvanced
$354M
-
-$0.67
0.11
-
Price and volume
Market cap
$354M
Beta
0.11
52-week high
$4.50
52-week low
$0.60
Average daily volume
2.1M
Financial strength
Current ratio
1.618
Quick ratio
1.331
Long term debt to equity
-1,071.208
Total debt to equity
-1,152.487
Interest coverage (TTM)
-4.33%
Profitability
EBITDA (TTM)
-40.035
Gross margin (TTM)
15.02%
Net profit margin (TTM)
-15.53%
Operating margin (TTM)
-11.05%
Effective tax rate (TTM)
0.20%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
-17.27%
Return on equity (TTM)
-651.69%
Valuation
Price to revenue (TTM)
0.718
Price to book
-39.35
Price to tangible book (TTM)
-12.33
Price to free cash flow (TTM)
-23.306
Free cash flow yield (TTM)
-4.29%
Free cash flow per share (TTM)
-0.163
Growth
Revenue change (TTM)
17.53%
Earnings per share change (TTM)
-14.81%
3-year revenue growth (CAGR)
24.36%
3-year earnings per share growth (CAGR)
210.38%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for The Oncology Institute Inc. stock?
The Oncology Institute Inc. (TOI) has a market cap of $354M as of August 23, 2025.
What is the P/E ratio for The Oncology Institute Inc. stock?
The price to earnings (P/E) ratio for The Oncology Institute Inc. (TOI) stock is 0 as of August 23, 2025.
Does The Oncology Institute Inc. stock pay dividends?
No, The Oncology Institute Inc. (TOI) stock does not pay dividends to its shareholders as of August 23, 2025.
When is the next The Oncology Institute Inc. dividend payment date?
The Oncology Institute Inc. (TOI) stock does not pay dividends to its shareholders.
What is the beta indicator for The Oncology Institute Inc.?
The Oncology Institute Inc. (TOI) has a beta rating of 0.11. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.